Herpes zoster subunit vaccine for patients initiating a Janus kinase inhibitor

J Am Acad Dermatol. 2023 Mar;88(3):697-698. doi: 10.1016/j.jaad.2022.08.040. Epub 2022 Aug 28.

Authors

Reid A Waldman¹, Kelley L Sharp², Jonas A Adalsteinsson³, Jane M Grant-Kels³

Affiliations

¹ Dermatology Associates of Glastonbury, Glastonbury, Connecticut. Electronic address: [email protected].
² Quinnipiac University Frank H. Netter MD School of Medicine, North Haven, Connecticut.
³ Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut.

PMID: 36041555
DOI: 10.1016/j.jaad.2022.08.040

No abstract available

MeSH terms

Adjuvants, Immunologic
Herpes Zoster Vaccine*
Herpes Zoster* / prevention & control
Herpesvirus 3, Human
Humans
Janus Kinase Inhibitors*
Vaccines, Subunit

Substances

Herpes Zoster Vaccine
Janus Kinase Inhibitors
Adjuvants, Immunologic
Vaccines, Subunit